Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
GILD
GILD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GILD News
Gilead Sciences Stock Rises Ahead of Positive Earnings Outlook
20h ago
NASDAQ.COM
Latest Wall Street Rating Updates
6h ago
CNBC
Three Blue-Chip Stocks Designed for a Shifting Market
2d ago
Marketbeat
FDA Vaccine and Biotech Chief Resigns Amid Industry Criticism
3d ago
CNBC
Analysis of QQQM ETF's 52-Week Price Fluctuations
4d ago
NASDAQ.COM
Stock Futures Plunge as Jefferies Faces Lawsuit Over $126.4M Claim
4d ago
seekingalpha
Three Cash Flow Generators Offer Stability in Volatile Markets
4d ago
Marketbeat
South Africa in Talks with Gilead for HIV Therapy Production Agreement
4d ago
seekingalpha
Gilead Executive Anticipates Anti-Cel Launch by Year-End at TD Cowen Conference
Mar 03 2026
moomoo
Gilead Executive Highlights Potential $20 Billion Market for Anti-Cel in First-Line Multiple Myeloma Treatment at TD Cowen Conference
Mar 03 2026
moomoo
Gilead Foundation Invests $12 Million to Strengthen HIV Prevention Efforts
Mar 02 2026
Newsfilter
Significant Milestones in Biotech Sector This Week
Feb 27 2026
NASDAQ.COM
Novartis and Genentech Sue Over Drug Importation
Feb 26 2026
Newsfilter
Novartis and Genentech Sue Over Illegal Drug Import Scheme
Feb 26 2026
CNBC
Analysis of DFAC Stock's 52-Week High and Low Points
Feb 26 2026
NASDAQ.COM
Barron’s Top Fund Families for 2025
Feb 26 2026
Barron's
Show More News
